Stockreport

Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed [Yahoo! Finance]

Nasus Pharma Ltd. Ordinary Shares  (NSRX) 
PDF Previous clinical study demonstrated NS002 can achieve faster and higher absorption of epinephrine compared to an autoinjector Dosing of the first participant in the [Read more]